Archigef 250 Tablet
Marketer
Archerchem Healthcare Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Archigef 250 Tablet
Afgect 250 mg tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should strictly follow your physician's instructions; continue treatment for the duration they specify. Treatment length depends on individual response. Regular liver function checks may be recommended. Common adverse reactions include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may mitigate some side effects. Report any concerning or worsening side effects to your doctor immediately. Seek immediate medical attention if you experience oral ulcers, vision changes, or respiratory distress. Women undergoing treatment must employ effective contraception and avoid pregnancy throughout treatment and for one month post-treatment. Always inform your doctor of all other medications you are currently using.
Primary Ingredients of Archigef 250 Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Archigef 250 Tablet
Lung cancer (excluding small cell types)
Major Benefits of Archigef 250 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Archigef 250 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Archigef 250 Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Archigef 250 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Archigef 250 Tablet. Swallow the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Archigef 250 Tablet works:
Oncasin 250mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Archigef 250 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Archigef 250 Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Use of Archigef 250 Tablet while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Archigef 250 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Archigef 250 Tablets cautiously. Dosage modification for Archigef 250 Tablets may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Archigef 250 Tablet is likely safe for individuals with liver conditions. Existing evidence indicates dose modification may be unnecessary, but medical advice is recommended.
What if you forget to take Archigef 250 Tablet :
Omit any missed Archigef 250 Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Archigef 250 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Quinazoline amines |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
3,018 People bought this recently